Myeloproliferative disorders: II CML: Clonal evolution and its role in management
- 31 December 1979
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 3 (6), 379-393
- https://doi.org/10.1016/0145-2126(79)90035-3
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)Blood, 1979
- Correlation of a specific chromosomal marker, 21q-, and retroviral indicators in patients with thrombocythemiaCancer Letters, 1979
- Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1978
- THE PATHOGENESIS OF MYELOPROLIFERATIVE SYNDROMESBritish Journal of Haematology, 1978
- Analysis of Platelets From Patients With Thrombocythemia for Reverse Transcriptase and Virus-Like Particles2JNCI Journal of the National Cancer Institute, 1975
- Removal of abnormal clone of leukaemic cells by splenectomy.BMJ, 1975
- SPLENIC LYMPHOCYTES IN CHRONIC MYELOID LEUKÆMIAThe Lancet, 1974
- The Origin and Development of Human Tumors Studied with Cell MarkersNew England Journal of Medicine, 1974
- INCREASE OF T LYMPHOCYTES IN THE SPLEEN IN CHRONIC GRANULOCYTIC LEUKÆMIAThe Lancet, 1974
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958